1 Sustained weight loss of 5-10% has been shown to significantly reduce the risk of developing obesity-related comorbidities, with the risk of developing diabetes reduced by up to 60% in overweight and obese adults who sustained weight loss for at least two years
Vitamin D signaling in the context of innate immunity: focus on human monocytes
GLP-1R agonist can slow down the AD process by reducing A deposition and inhibiting tau protein hyperphosphorylation (Singh et al., 2024
Front Nutr 7:592777 Zhiqing W, Jing W, Haili X, Shaozhuang L, Chunxiao H, Haifeng H, Hui W, Sanyuan H (2014) Renal function is ameliorated in a diabetic nephropathy rat model through a duodenal-jejunal bypass
Due to its broad mechanism of action, retatrutide is frequently considered a next-generation GLP-based research compound and a leading focus in modern metabolic studies
As we get older, the production of both slows down